Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib in Treating Patients With Lymphoproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Children With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PS-341 in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib in Treating Patients With Recurrent Glioma
- Status
- TERMINATED
- Phase
- PHASE1
PS-341 in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
PS-341 in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1